# Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

> **NCT00351130** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 79 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan
- **DRUG:** amlodipine

## Key facts

- **NCT ID:** NCT00351130
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351130, "Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00351130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*